Goal Reached Thanks to every supporter — we hit 100%!

Goal: 1000 CNY · Raised: 1000 CNY

100.0%
Get alerts for future matching vulnerabilitiesLog in to subscribe
I. Basic Information for CVE-2023-43041
Vulnerability Information

Have questions about the vulnerability? See if Shenlong's analysis helps!
View Shenlong Deep Dive ↗

Although we use advanced large model technology, its output may still contain inaccurate or outdated information.Shenlong tries to ensure data accuracy, but please verify and judge based on the actual situation.

Vulnerability Title
IBM QRadar information disclosure
Source: NVD (National Vulnerability Database)
Vulnerability Description
IBM QRadar SIEM 7.5 is vulnerable to information exposure allowing a delegated Admin tenant user with a specific domain security profile assigned to see data from other domains. This vulnerability is due to an incomplete fix for CVE-2022-34352. IBM X-Force ID: 266808.
Source: NVD (National Vulnerability Database)
CVSS Information
CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:H/I:N/A:N
Source: NVD (National Vulnerability Database)
Vulnerability Type
信息暴露
Source: NVD (National Vulnerability Database)
Vulnerability Title
IBM QRadar SIEM 安全漏洞
Source: CNNVD (China National Vulnerability Database)
Vulnerability Description
IBM QRadar SIEM是美国国际商业机器(IBM)公司的一套利用安全智能保护资产和信息远离高级威胁的解决方案。该方案提供对整个IT架构范围进行监督、生成详细的数据访问和用户活动报告等功能。 IBM QRadar SIEM 7.5版本存在安全漏洞,该漏洞源于存在信息泄露漏洞,允许具有指定域安全配置文件的管理员用户查看其他域的数据。
Source: CNNVD (China National Vulnerability Database)
CVSS Information
N/A
Source: CNNVD (China National Vulnerability Database)
Vulnerability Type
N/A
Source: CNNVD (China National Vulnerability Database)
Affected Products
VendorProductAffected VersionsCPESubscribe
IBMQRadar SIEM 7.5 -
II. Public POCs for CVE-2023-43041
#POC DescriptionSource LinkShenlong Link
AI-Generated POCPremium

No public POC found.

Login to generate AI POC
III. Intelligence Information for CVE-2023-43041
Please Login to view more intelligence information
IV. Related Vulnerabilities
V. Comments for CVE-2023-43041

No comments yet


Leave a comment